Dullens H F, Den Otter W
Immunol Lett. 1983 Jun;6(6):309-10. doi: 10.1016/0165-2478(83)90072-x.
It is generally known that many malignancies are accompanied by forms of impairment of the immune system of the host. Also P815 mastocytoma cells can exert suppressive effects on the immune response reaction in vivo and in vitro. However, we have found a product released by P815 cells, which is able to activate macrophages non-specifically; macrophages normally not cytotoxic against tumor cells become cytotoxic against various tumor cell lines upon incubation with the P815 product. Nevertheless the same product which induces macrophage activation in vitro, seems to cause enhancement of tumor growth in vivo. We feel, if the activity of a tumor product depends so strongly on the experimental conditions used, one should be very careful in interpreting the results of experiments in which P815 cells are used as target cells.
众所周知,许多恶性肿瘤都伴随着宿主免疫系统的某种形式的损伤。此外,P815肥大细胞瘤细胞在体内和体外都能对免疫反应产生抑制作用。然而,我们发现P815细胞释放的一种产物能够非特异性地激活巨噬细胞;正常情况下对肿瘤细胞无细胞毒性的巨噬细胞,在与P815产物孵育后,对各种肿瘤细胞系具有细胞毒性。然而,在体外诱导巨噬细胞激活的同一产物,在体内似乎会导致肿瘤生长增强。我们认为,如果一种肿瘤产物的活性如此强烈地依赖于所使用的实验条件,那么在解释以P815细胞作为靶细胞的实验结果时应该非常谨慎。